Literature DB >> 22158717

Antibodies to low density lipoprotein receptor-related protein 4 in seronegative myasthenia gravis.

David P Richman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22158717      PMCID： PMC3903387          DOI： 10.1001/archneurol.2011.2855

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  11 in total

1.  Agrin acts via a MuSK receptor complex.

Authors:  D J Glass; D C Bowen; T N Stitt; C Radziejewski; J Bruno; T E Ryan; D R Gies; S Shah; K Mattsson; S J Burden; P S DiStefano; D M Valenzuela; T M DeChiara; G D Yancopoulos
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

2.  Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

Authors:  Alexandra Pevzner; Benedikt Schoser; Katja Peters; Nicoleta-Carmen Cosma; Andromachi Karakatsani; Berthold Schalke; Arthur Melms; Stephan Kröger
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

3.  Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.

Authors:  Bin Zhang; John S Tzartos; Maria Belimezi; Samia Ragheb; Beverly Bealmear; Richard A Lewis; Wen-Cheng Xiong; Robert P Lisak; Socrates J Tzartos; Lin Mei
Journal:  Arch Neurol       Date:  2011-12-12

4.  Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.

Authors:  David P Richman; Kayoko Nishi; Stuart W Morell; Jolene Mi Chang; Michael J Ferns; Robert L Wollmann; Ricardo A Maselli; Joachim Schnier; Mark A Agius
Journal:  Arch Neurol       Date:  2011-12-12

5.  Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK).

Authors:  Smita Jha; Kaiping Xu; Takahiro Maruta; Minako Oshima; Dennis R Mosier; M Zouhair Atassi; Werner Hoch
Journal:  J Neuroimmunol       Date:  2006-05-11       Impact factor: 3.478

6.  Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.

Authors:  Osamu Higuchi; Johko Hamuro; Masakatsu Motomura; Yuji Yamanashi
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

7.  LRP4 serves as a coreceptor of agrin.

Authors:  Bin Zhang; Shiwen Luo; Qiang Wang; Tatsuo Suzuki; Wen C Xiong; Lin Mei
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

8.  Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.

Authors:  Rebecca N Cole; Stephen W Reddel; Othon L Gervásio; William D Phillips
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

9.  Lrp4 is a receptor for Agrin and forms a complex with MuSK.

Authors:  Natalie Kim; Amy L Stiegler; Thomas O Cameron; Peter T Hallock; Andrea M Gomez; Julie H Huang; Stevan R Hubbard; Michael L Dustin; Steven J Burden
Journal:  Cell       Date:  2008-10-09       Impact factor: 41.582

10.  Induction of myasthenia by immunization against muscle-specific kinase.

Authors:  Kazuhiro Shigemoto; Sachiho Kubo; Naoki Maruyama; Naohito Hato; Hiroyuki Yamada; Chen Jie; Naoto Kobayashi; Katsumi Mominoki; Yasuhito Abe; Norifumi Ueda; Seiji Matsuda
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808
View more
  3 in total

Review 1.  Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies.

Authors:  Francesca Andreetta; Elena Rinaldi; Emanuela Bartoccioni; Anna Pia Riviera; Elena Bazzigaluppi; Raffella Fazio; Giovanni Deiana; Alessandro Pini; Maria Grazia Giudizi; Fulvio Baggi
Journal:  Neurol Sci       Date:  2017-10       Impact factor: 3.307

Review 2.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

3.  Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.

Authors:  Mariapaola Marino; Flavia Scuderi; Daniela Samengo; Giorgia Saltelli; Maria Teresa Maiuri; Chengyong Shen; Lin Mei; Mario Sabatelli; Giovambattista Pani; Giovanni Antonini; Amelia Evoli; Emanuela Bartoccioni
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.